Related Experiment Video
Updated: Jul 11, 2026

Polycrystalline Silicon Thin-film Solar cells with Plasmonic-enhanced Light-trapping
Published on: July 2, 2012
Bio-inspired Plasmonic Nanoarchitectured Hybrid System Towards Enhanced Far Red-to-Near Infrared Solar Photocatalysis
Runyu Yan1, Min Chen1, Han Zhou1
1State Key Lab of Metal Matrix Composites, Department of Materials Science and Engineering, Shanghai Jiaotong University, Shanghai, 200240, China.
Abstract:
Solar conversion to fuels or to electricity in semiconductors using far red-to-near infrared (NIR) light, which accounts for about 40% of solar energy, is highly significant. One main challenge is the development of novel strategies for activity promotion and new basic mechanisms for NIR response. Mother Nature has evolved to smartly capture far red-to-NIR light via their intelligent systems due to unique micro/nanoarchitectures, thus motivating us for biomimetic design. Here we report the first demonstration of a new strategy, based on adopting nature's far red-to-NIR responsive architectures for an efficient bio-inspired photocatalytic system. The system is constructed by controlled assembly of light-harvesting plasmonic nanoantennas onto a typical photocatalytic unit with butterfly wings' 3D micro/nanoarchitectures. Experiments and finite-difference time-domain (FDTD) simulations demonstrate the structural effects on obvious far red-to-NIR photocatalysis enhancement, which originates from (1) Enhancing far red-to-NIR (700~1200 nm) harvesting, up to 25%. (2) Enhancing electric-field amplitude of localized surface plasmon (LSPs) to more than 3.5 times than that of the non-structured one, which promotes the rate of electron-hole pair formation, thus substantially reinforcing photocatalysis. This proof-of-concept study provides a new methodology for NIR photocatalysis and would potentially guide future conceptually new NIR responsive system designs.
Related Concept Videos
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Oral Hypoglycemic Agents: Sulfonylureas
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...

